Voyager Therapeutics Total Risk Alpha
| VYGR Stock | | | USD 4.17 0.27 6.92% |
Total Risk Alpha measures the excess return of an asset after comparing its performance to a benchmark portfolio matched to the same total risk level. Unlike Jensen Alpha, which adjusts for systematic risk (beta) only, Total Risk Alpha accounts for total volatility. Below is Voyager Therapeutics's current Total Risk Alpha with peer comparisons and related risk metrics.
Current Total Risk Alpha Value
At 0.2954, Voyager Therapeutics's Total Risk Alpha indicates positive alpha — return above what market exposure alone would predict. Voyager Therapeutics has generated modest excess return beyond what its systematic risk exposure explains.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.2954 | |
| ER[a] | = | Expected return on investing in Voyager Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Voyager Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Among sector peers, Voyager Therapeutics's Total Risk Alpha of 0.2954 is below the 0.53 group average. The range runs from 0.1826 (Vanda Pharmaceuticals) to 0.8169 (Sagimet Biosciences Series). Voyager Therapeutics has generated less excess return relative to its market exposure than the peer group average.
Total Risk Alpha Relative To Other Indicators
The chart below plots Total Risk Alpha against Maximum Drawdown for Voyager Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Total Risk Alpha while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Voyager Therapeutics's Total Risk Alpha reads
0.30 while Maximum Drawdown reads
30.91 , a
104.65 ratio between the two. This indicates Maximum Drawdown substantially exceeds Total Risk Alpha for Voyager Therapeutics.
Methodology, Assumptions & Data Sources
Voyager Therapeutics' Total Risk Alpha currently stands at 0.2954. This Total Risk Alpha reading for Voyager Therapeutics results from applying the indicator's calculation rules to price and volume data over the selected window. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators